Septerna, Inc. (SEPN)
NASDAQ: SEPN · Real-Time Price · USD
37.34
+2.80 (8.11%)
At close: Jun 26, 2026, 4:00 PM EDT
37.17
-0.17 (-0.46%)
After-hours: Jun 26, 2026, 5:04 PM EDT
Septerna Employees
Septerna had 130 employees as of December 31, 2025. The number of employees increased by 55 or 73.33% compared to the previous year.
Employees
130
Change (1Y)
55
Growth (1Y)
73.33%
Revenue / Employee
$555,808
Profits / Employee
-$277,231
Market Cap
1.68B
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 130 | 55 | 73.33% |
| Dec 31, 2024 | 75 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| Ascentage Pharma Group International | 767 |
| Immunocore Holdings | 524 |
| Ardelyx | 489 |
| Maravai LifeSciences Holdings | 416 |
| Vir Biotechnology | 367 |
| Zenas BioPharma | 167 |
| Maze Therapeutics | 141 |
| Absci | 140 |
SEPN News
- 15 days ago - Septerna initiated with a Buy at Guggenheim - TheFly
- 18 days ago - Septerna to present preclinical characterization of SEP-479 - TheFly
- 18 days ago - Septerna to Present Preclinical Characterization of SEP-479, an Oral PTH1R Agonist for Hypoparathyroidism, at 2026 ENDO Annual Meeting - Business Wire
- 18 days ago - Septerna price target raised to $53 from $47 at Raymond James - TheFly
- 4 weeks ago - 3 Unknown Small-Cap Stocks with ‘Strong Buy’ Ratings and Up to 70% Upside in 2026 - TipRanks
- 6 weeks ago - Septerna Transcript: Bank of America Global Healthcare Conference 2026 - Transcripts
- 6 weeks ago - Septerna reports Q1 EPS (19c), consensus (27c) - TheFly
- 6 weeks ago - Septerna Highlights Business Progress and Reports First Quarter 2026 Financial Results - GlobeNewsWire